Waldencast (NASDAQ: WALD) shares surged 14.8% to $2.79 in pre-market trading on Wednesday, July 23, 2025, up from the previous close of $2.43.
The rally follows news that Waldencast has acquired Novaestiq Corp., a move set to broaden Obagi Medical’s portfolio beyond U.S. medical-grade skincare. The deal includes upfront cash, ongoing royalties from Saypha® sales, and a potential issuance of Waldencast class A shares. Increased investor interest is reflected in elevated pre-market volume.
